Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Medicenna Therapeutics Co...

    NASDAQ: MDNA · Real-Time Price · USD
    0.16
    0.00 (1.91%)
    At close: Jan 16, 2025, 10:00 PM

    Medicenna Therapeutics Statistics

    Share Statistics

    Medicenna Therapeutics has 0 shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 48.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,796

    FTD / Avg. Volume

    n/a
    		 0.54%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 35.63 and the forward PE ratio is null. Medicenna Therapeutics's PEG ratio is -0.34.

    PE Ratio

    n/a
    		 35.63

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.87

    P/FCF Ratio

    n/a
    		 -4.35

    PEG Ratio

    n/a
    		 -0.34
    Financial Ratio History

    Enterprise Valuation

    Medicenna Therapeutics has an Enterprise Value (EV) of 21.52M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -1.32

    EV / EBIT

    n/a
    		 -1.7

    EV / FCF

    n/a
    		 -1.7

    Financial Position

    The company has a current ratio of 9.57, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 9.57

    Quick Ratio

    n/a
    		 9.57

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is 5.25% and Return on Invested Capital is 7.69%.

    Return on Equity

    n/a
    		 5.25%

    Return on Assets

    n/a
    		 4.24%

    Return on Invested Capital

    n/a
    		 7.69%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $96,687.5

    Employee Count

    n/a
    		 16

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -11.6M

    Effective Tax Rate

    n/a
    		 115.4%

    Stock Price Statistics

    The stock price has increased by -56.16% in the last 52 weeks. The beta is 0.77, so Medicenna Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.77

    52-Week Price Change

    n/a
    		 -56.16%

    50-Day Moving Average

    n/a
    		 0.29

    200-Day Moving Average

    n/a
    		 0.48

    Relative Strength Index (RSI)

    n/a
    		 33.89

    Average Volume (20 Days)

    n/a
    		 1,255,845

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -16.3M

    Net Income

    n/a
    		 1.55M

    EBITDA

    n/a
    		 -16.3M

    EBIT

    n/a
    		 -21.64M

    Earnings Per Share (EPS)

    n/a
    		 0.02
    Full Income Statement

    Balance Sheet

    The company has 33.6M in cash and 0 in debt, giving a net cash position of 33.6M.

    Cash & Cash Equivalents

    n/a
    		 33.6M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -80.98M

    Total Assets

    n/a
    		 27.74M

    Working Capital

    n/a
    		 23.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.66M and capital expenditures 0, giving a free cash flow of -12.66M.

    Operating Cash Flow

    n/a
    		 -12.66M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.66M

    FCF Per Share

    n/a
    		 -0.2
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    MDNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 2.81%

    FCF Yield

    n/a
    		 -22.96%
    Dividend Details

    Analyst Forecast

    The average price target for MDNA is $2.5, which is 1462.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $2.5

    Price Target Difference

    n/a
    		 1462.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.13

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist